1. Home
  2. Stocks
  3. Nathbiogen Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Nath Bio-Genes (India) Share Price Nath Bio-Genes (India)

    Small Cap
    ₹203.4
    +3.25 (1.62%)
    23 April, 2024 12:39 BSE: 537291 NSE: NATHBIOGENISIN: INE448G01010

    Start SIP in Nath Bio-Genes (India)

    Start SIP

    Nath Bio-Genes (India) Performance

    Day Range

    • Low 197
    • High 205
    ₹ 203

    52 Week Range

    • Low 157
    • High 245
    ₹ 203
    • Open Price201
    • Previous Close200
    • Volume63185

    Nath Bio-Genes (India) Share Price

    • Over 1 Month +11.25%
    • Over 3 Month -11.52%
    • Over 6 Month +2.42%
    • Over 1 Year +20.73%

    Nath Bio-Genes (India) Key Statistics

    P/E Ratio 9.4
    PEG Ratio 0.1
    Market Cap Cr 387
    Price to Book Ratio 0.7
    EPS 18.5
    Dividend 1
    Relative Strength Index 59.36
    Money Flow Index 74.26
    MACD Signal -1.74
    Average True Range 7.97
    Nath Bio-Genes (India) Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 322323545
    Operating Expenses Qtr Cr 261719841
    Operating Profit Qtr Cr 66374
    Depreciation Qtr Cr 1111
    Interest Qtr Cr 3232
    Tax Qtr Cr 1000
    Net Profit Qtr Cr 42332
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 302
    Operating Expenses Annual Cr 252
    Operating Profit Annual in Cr 49
    Depreciation Cr 3
    Interest Annual Cr 10
    Tax Annual Cr 1
    Net Profit Annual Cr 35
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 38
    Cash from Investing Activity Annual Cr -3
    Cash from Financing Annual Activity Cr -2
    Net Cash Flow Annual Cr 34
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 573
    Fixed Assets Annual Cr 244
    Total Non Current Assets Annual Cr 272
    Total Current Assets Annual Cr 521
    Total Assets Annual Cr 793
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 302
    ROE Annual % 6
    ROCE Annual % 8
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 16
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 3223235
    Operating Expenses Qtr Cr 2617198
    Operating Profit Qtr Cr 6637
    Depreciation Qtr Cr 111
    Interest Qtr Cr 323
    Tax Qtr Cr 100
    Net Profit Qtr Cr 4233
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 302
    Operating Expenses Annual Cr 253
    Operating Profit Annual in Cr 49
    Depreciation Cr 3
    Interest Annual Cr 10
    Tax Annual Cr 1
    Net Profit Annual Cr 35
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 38
    Cash from Investing Activity Annual Cr -3
    Cash from Financing Annual Activity Cr -2
    Net Cash Flow Annual Cr 34
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 573
    Fixed Assets Annual Cr 244
    Total Non Current Assets Annual Cr 272
    Total Current Assets Annual Cr 521
    Total Assets Annual Cr 793
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 302
    ROE Annual % 6
    ROCE Annual % 8
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 16
    Sign Up to Know More
    Invest in Nath Bio-Genes (India)

    Nath Bio-Genes (India) Technicals

    EMA & SMA

    Current Price
    ₹203.4
    +3.25 (1.62%)
    pointer
    • Bullish Moving Average
    • ___
    • 15
    • Bearish Moving Average
    • ___
    • 1
    • 20 Day
    • ₹190.63
    • 50 Day
    • ₹195.00
    • 100 Day
    • ₹199.02
    • 200 Day
    • ₹198.47
    • 20 Day
    • ₹187.31
    • 50 Day
    • ₹197.14
    • 100 Day
    • ₹203.14
    • 200 Day
    • ₹205.79

    Nath Bio-Genes (India) Resistance and Support

    PIVOT
    ₹198.7
    Resistance
    First Resistance 202.95
    Second Resistance 205.75
    Third Resistance 210.00
    RSI 59.36
    MFI 74.26
    MACD Single Line -1.74
    MACD -0.02
    Support
    First Resistance 195.90
    Second Resistance 191.65
    Third Resistance 188.85

    Nath Bio-Genes (India) Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 82,959 5,190,745 62.57
    Week 42,367 2,489,909 58.77
    1 Month 47,353 2,963,832 62.59
    6 Month 90,311 5,494,513 60.84

    Nath Bio-Genes (India) Result Highlights

    Nath Bio-Genes (India) Synopsis

    NSE-Agricultural Operations

    Nath Bio-Genes is involved in the business activities of Growing of non-perennial crops. Company’s Total Operating Revenue is Rs. 301.29 Cr. and Equity Capital is Rs. 19.00 Cr. for the Year ended 31/03/2023. Nath Bio-Genes (India) Ltd. is a Public Limited Listed company incorporated on 14/07/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L01110MH1993PLC072842 and registration number is 072842.
    Market Cap 386
    Sales 335
    Shares in Float 1.03
    No of funds 14
    Yield 1.05
    Book Value 0.66
    U/D Vol ratio 0.7
    LTDebt / Equity
    Alpha -0.08
    Beta 1.39

    Nath Bio-Genes (India)

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 45.6%45.6%45.6%45.6%
    Mutual Funds 4.37%4.37%4.37%4.62%
    Foreign Portfolio Investors 0.27%0.32%0.22%0.07%
    Financial Institutions/ Banks
    Individual Investors 32.25%30.96%30.5%30.37%
    Others 17.51%18.75%19.31%19.34%

    Nath Bio-Genes (India) Management

    Name Designation
    Mr. Satish Kagliwal Managing Director
    Mr. Madhukar Deshpande Director
    Ms. Ashu Jain Director
    Mrs. Jeevanlata Kagliwal Director
    Mr. Vadla Nagabhushanam Director
    Mrs. Sweta Kagliwal Director
    Mr. Hitesh Purohit Director

    Nath Bio-Genes (India) Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Nath Bio-Genes (India) Corporate Action

    Date Purpose Remarks
    2024-01-18 Quarterly Results
    2023-10-16 Quarterly Results
    2023-08-10 Quarterly Results
    2023-04-22 Audited Results & Final Dividend
    2023-02-14 Quarterly Results

    Nath Bio-Genes (India) MF Shareholding

    Name Amount(cr)
    Aditya Birla Sun Life Pure Value Fund Growth 5,684

    Nath Bio-Genes (India) FAQs

    What is Share Price of Nath Bio-Genes (India) ?

    Nath Bio-Genes (India) share price is ₹203 As on 23 April, 2024 | 12:25

    What is the Market Cap of Nath Bio-Genes (India) ?

    The Market Cap of Nath Bio-Genes (India) is ₹386.5 Cr As on 23 April, 2024 | 12:25

    What is the P/E ratio of Nath Bio-Genes (India) ?

    The P/E ratio of Nath Bio-Genes (India) is 9.4 As on 23 April, 2024 | 12:25

    What is the PB ratio of Nath Bio-Genes (India) ?

    The PB ratio of Nath Bio-Genes (India) is 0.7 As on 23 April, 2024 | 12:25

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.